Thermo Fisher Scientific reports $11.01 billion revenue for quarter ended March 28, 2026, up 6.2%
Thermo Fisher Scientific reported revenue of $11.01 billion for the quarter ended March 28, 2026, an increase of 6.2% from the same quarter a year earlier ($10.36 billion).
For the same period it posted net income of $1.65 billion, up 9.6%, or $4.43 per diluted share (3.98 a year earlier).
That is a net margin of 15%.
On Sanad's AAOIFI Standard 21 screen, Thermo Fisher Scientific is currently compliant: interest-bearing debt is 16.3% of market capitalisation (limit 30%), and impure income is 2.2% of revenue (limit 5%).
Is Thermo Fisher Scientific halal?
See the full AAOIFI screening of Thermo Fisher Scientific
See the full AAOIFI screening of Thermo Fisher Scientific
Source: 10-Q filed with the U.S. Securities and Exchange Commission on May 1, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.